logo
Ola Electric, TVS charge up plans to beat rare-earth magnet crunch

Ola Electric, TVS charge up plans to beat rare-earth magnet crunch

Ferrite magnets are now globally considered a viable and cost-effective option due to their easy availability instead of rare-earth materials like neodymium, making it an affordable option
Surajeet Das Gupta New Delhi
Listen to This Article
Ola Electric is planning to launch in the third quarter (September-December) some of its electric vehicles powered with ferrite motors as an alternative to those that go with heavy rare-earth magnets, whose supply the Chinese government has choked.
Government sources Ola is in discussion with have said the company has been working for over two years on developing the technology and design for ferrite motors, where the magnet is made of iron (with some other metals added). The prototype has been internally validated and is being tested on some of its vehicles.
The company has to go to the Automotive
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mukul Agrawal portfolio stock up 87% from April; what's behind the rally?
Mukul Agrawal portfolio stock up 87% from April; what's behind the rally?

Business Standard

time34 minutes ago

  • Business Standard

Mukul Agrawal portfolio stock up 87% from April; what's behind the rally?

Tatva Chintan Pharma Chem share price today Shares of Tatva Chintan Pharma Chem hit a 52-week high of ₹1,139, as they surged 12 per cent on the BSE in Friday's intra-day trade in an otherwise weak market. A sharp surge in stock price after the company reported healthy earnings for the quarter ended June 2025 (Q1FY26). The stock price of the smallcap specialty chemicals surpassed its previous high of ₹1,101.40 touched on September 25, 2024. It has zoomed by 87 per cent from its 52-week low of ₹610 hit on April 7, 2025. At 09:40 AM; Tatva Chintan Pharma Chem was trading 10 per cent higher at ₹1,119.15, as compared to 0.35 per cent decline in the BSE Sensex. Q1 results - Tatva Chintan Pharma Chem For the April to June 2025 quarter (Q1FY26), Tatva Chintan Pharma Chem reported 33.7 per cent year-on-year (YoY) jump in consolidated profit after tax at ₹6.65 crore. Revenue from operations grew 10.8 per cent at ₹116.86 crore. Earnings before interest, taxes, depreciation, and amortization (EBITDA) grew 37.4 per cent YoY at ₹17.33 crore; margins improvement 280 bps at 14.8 per cent. The company manufactures Structure Directing Agents (SDA), Phase Transfer Catalysts, Electrolyte Salts for Super Capacitor Batteries and Pharma & Agro Intermediates and Specialty Chemicals. Trends in specialty chemicals landscape The Indian chemical industry got advantage vs China due to Trust deficit between China and the US; stringent environmental regulations since 2015 and large-scale shutdowns in China; customers preference to de-risk the supply chain led to China+1 policy; geopolitical shift after the outbreak of Covid-19 and increased cost of labour. With an increasing awareness of the ill effects of certain chemicals on humans and the environment, there is a growing trend in the chemicals industry to shift towards what is known as 'green' chemicals or more accurately sustainable chemistry. Meanwhile, China holds 39% share in the global chemical industry of which exportable specialty chemicals accounts for ~15-17 per cent while India accounts for merely 1-2 per cent indicating widespread opportunity. The spillover impact of China's declining competitiveness has set the stage for India to intensify its effort to capture larger market share, the company said. Meanwhile, during FY 25, one of the major products of the company SDA (Structure Directing Agents) saw moderation in offtake from its major export destination which is China. Due to higher adoption of LNG Powered trucks by Chinese companies, the company saw substantial decline in SDA demand from Chinese consumers. Further, the Group will be entering into the commercial phase of new products in FY 26 and offtake of new products will be crucial for improvement of business risk profile, Crisil Ratings said in its rationale. Mukul Mahavir Agrawal holds over 1 per cent holding in Tatva Chintan Pharma Chem Investor Mukul Mahavir Agrawal held 300,000 equity shares or 1.28 per cent stake in Tatva Chintan Pharma Chem at the end of June 2025 quarter, the shareholding pattern data shows. Mukul Agrawal held NIL or less than 1 per cent holding in the company at the end of March 2025 quarter, the data shows. According to information available, Mukul Mahavir Agrawal holds over 1 per cent stake in other notable listed companies, including BSE, Neuland Laboratories, Radico Khaitan, Nuvama Wealth Management, PTC Industries and LT Foods.

India flexible on Chinese investments in electronics: Govt source
India flexible on Chinese investments in electronics: Govt source

News18

timean hour ago

  • News18

India flexible on Chinese investments in electronics: Govt source

New Delhi, Jul 25 (PTI) India is flexible for collaboration of domestic companies with Chinese, especially electronics, a government source said on Friday. Around 60 per cent of electronics manufacturing happens in China, and hence, it is not easy to ignore it, the source added. 'Things are easing (between India and China). There are signals. Tourist visas have been opened. In electronics, 60 per cent of manufacturing takes place in China. So, there has to be some sort of collaboration," the sources said. He was replying to a question on government approval for the Dixon joint venture with Chinese companies. Dixon Technologies has received approval from the Indian government to form a joint venture (JV) with Chinese peer Longcheer. Dixon has been reaching out to several Chinese companies for joint ventures. It has signed separate agreements with Chinese electronic component firms — Chongqing Yuhai Precision Manufacturing Co Ltd and the Indian arm of Kunshan Q Technology — for manufacturing and sales of electronic components used in electronic devices like mobile phones and laptops, among others. First Published: July 25, 2025, 13:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

ITC Chairman Puri unveils ₹20,000 crore expansion strategy at AGM 2025
ITC Chairman Puri unveils ₹20,000 crore expansion strategy at AGM 2025

Business Standard

timean hour ago

  • Business Standard

ITC Chairman Puri unveils ₹20,000 crore expansion strategy at AGM 2025

Diversified conglomerate ITC Ltd plans to invest ₹20,000 crore over the medium term to scale up its manufacturing operations across multiple sectors, Chairman Sanjiv Puri announced at the company's Annual General Meeting (AGM) on Friday. 'Our focus is on value accretion through new brand launches while reinforcing our footprint across India,' Puri said. The investment will enhance ITC's production capacity under its long-term growth strategy, with eight new manufacturing units already established in recent years. Puri reiterated ITC's commitment to its 'Bharat First' approach, which prioritises building a strong domestic presence before expanding globally. Q1 profit dips, but revenue grows 7.5% Earlier this month, ITC reported a marginal 0.26 per cent year-on-year decline in consolidated net profit for the April–June quarter (Q1 FY26), which stood at ₹5,091.59 crore, compared to ₹5,104.93 crore a year ago. The profit fell short of Bloomberg's estimate of ₹5,451 crore. However, consolidated gross revenue rose by 7.5 per cent to ₹20,029.60 crore. ITC described the quarterly performance as resilient despite a challenging macroeconomic environment. Growth was supported by cigarettes and non-cigarette FMCG, even as other segments faced pressure from subdued demand and a high base. At the AGM, Puri highlighted that 65 per cent of ITC's revenue now comes from non-cigarette businesses. Cigarettes see 5.8% revenue growth The cigarettes segment recorded a 5.8 per cent year-on-year increase in revenue to ₹8,842.22 crore. Pre-tax profit rose 6.29 per cent to ₹5,255.06 crore, aided by tax stability and enforcement measures that helped recover market share from illicit trade. FMCG business expands with packaged food and personal care Revenue from non-cigarette FMCG rose 6.3 per cent to ₹5,498.80 crore, with pre-tax profit increasing 10.4 per cent year-on-year to ₹479.17 crore. ITC attributed the growth to strong demand in packaged food and personal care categories. Hotel segment grows, but profits dip The hospitality segment saw revenue climb 14.29 per cent to ₹713.3 crore, but pre-tax profit declined 9 per cent to ₹122.21 crore. The dip was attributed to the operational impact of the newly launched luxury hotel, ITC Ratnadipa in Colombo. The company also added seven new managed properties during the quarter, including its first overseas Fortune Resort in Bhaktapur, Nepal. Paperboards face pricing pressure The Paperboards, Paper and Packaging segment recorded a 6.78 per cent drop in revenue to ₹1,976.85 crore, with pre-tax profit plunging 45.6 per cent to ₹256.15 crore. ITC cited high domestic wood prices and competition from low-cost Chinese imports as key challenges. Agri-business grows, but margins tighten Agri-business delivered strong top-line growth, with revenue up 22.19 per cent to ₹6,997.89 crore. However, pre-tax profit declined 2.2 per cent to ₹344.60 crore due to cost inflation in leaf tobacco and depreciation related to a new nicotine derivatives facility.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store